Boston Scientific (BSX) EBIT Growth (3y) (2012 - 2026)
Boston Scientific (BSX) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 13.06% |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | -0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.84% |
| Mar 31, 2026 | 25.88% |
| Dec 31, 2025 | 27.08% |
| Sep 30, 2025 | 43.05% |
| Jun 30, 2025 | 24.64% |
| Mar 31, 2025 | 25.49% |
| Dec 31, 2024 | 55.36% |
| Sep 30, 2024 | 23.73% |
| Jun 30, 2024 | 25.67% |
| Mar 31, 2024 | 22.19% |
| Dec 31, 2023 | 126.89% |
| Sep 30, 2023 | 75.23% |
| Jun 30, 2023 | 109.84% |
| Mar 31, 2023 | 55.79% |
| Dec 31, 2022 | 24.17% |
| Sep 30, 2022 | -2.22% |
| Jun 30, 2022 | 3.28% |
| Mar 31, 2022 | -4.85% |
| Dec 31, 2021 | -17.37% |
| Sep 30, 2021 | -0.09% |